New class of cholesterol drugs approved

FDA approved on Friday, July 24, the use of a new injectable cholesterol-lowering drug “Praluent” (alirocumab), the first injectable drug that lowers the cholesterol levels was approved by the The U.S. Food and Drug Administration. I could change cardiovascular care, by cutting levels of LDL (the “bad cholesterol), as experts explained. For now, the drug […]

Read More